Smith & Nephew PLC
SN.: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|zr% | LOCK|cr?T | LOCK|R<<>R@& |
Smith & Nephew Earnings: Sports Medicine Strength Offsets Knee Softness
Smith & Nephew saw abbreviated first-quarter results that included underlying revenue growth of 3%, with strong growth in sports medicine/joint repair (up 10%) and arthroscopic-enabling technologies (up 7%).
